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Purpose of the study: Older head and neck (H&N) cancer patients can present with 
significant co-morbidities whilst treatment induces additional morbidity. Comprehensive 
geriatric assessment (CGA) has been proposed as a key component in the treatment 
approach of older cancer patients. The feasibility of serial CGA during radiotherapy in older 
H&N cancer patients was studied. 
Material and methods: Patients aged ≥ 65 years with primary H&N cancer undergoing 
curative radiotherapy (with or without systemic treatment), were evaluated with the 
Vulnerable Elders Survey-13 (VES-13) and G8, and CGA as the gold standard, both at 
baseline (W0) and in the 4th week (W4) of their treatment at General Hospital Groeninge or 
Ghent University Hospital. 
Results: One hundred eligible patients with a median age of 72 (range 65-86) consented. 
Patients mostly presented with an advanced stage tumour (69.0%, stage III-IVB) of the 
larynx (45.0%), the pharynx (34.0%), the oral cavity (15.0%) or involved neck nodes of an 
occult primary (6.0%). Thirteen patients declined assessment in the 4th week of therapy. At 
baseline, 36.8%, 69.0% and 71.3% of patients were defined vulnerable, based on 
respectively the VES-13 (cut-off ≥3), G8 (cut-off ≤14) and CGA (defined as exhibiting 
impairments in ≥2 domains). Significantly more patients were considered vulnerable at week 
4 by VES-13 (57.5%, P<0.0001), G8 (92.0%, P<0.0001) and CGA (83.9%, P<0.01). Patients 
presented with deficits in the following domains: co-morbidity (CIRS-G, grade 3 or 4), 
nutrition (MNA), community functioning (IADL), physical status (Tinetti), emotional wellbeing 
(GDS), self-care (ADL), and cognition (MMSE) at both points in time (Table 1). In addition, 
the incidence of vulnerability in the health domains included within the CGA increased during 
treatment, with especially deterioration of nutritional (P<0.0001), functional (IADL, P<0.0001), 
emotional (P<0.01), and mental (P<0.01) status.  
Conclusions: Serial CGA identifies the multidimensional health problems and their evolution 
during radiotherapy. It indicates the need for re-evaluation of the patient’s health status and 
could guide intensive supportive care in older patients treated for H&N cancer.  
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Table 1: Vulnerability at weeks 0 and 4 of radiotherapy in 87 evaluable patientsa 
Screening tools Week 0 
Median score 
[Q1,Q3] 
Vulnerable 
patients W0 
N (%) 
Week 4 
Median score 
[Q1,Q3] 
Vulnerable 
patients W4 
N (%) 
p-value 
Vulnerable Elders Survey-13 
(VES-13; cut-off ≥3, range 0-10) 
1.0 [0.0, 5.0] 32 (36.8) 4.0 [1.0, 6.0] 50 (57.5) <0.00011 
G8-questionnaire 
(G8; cut-off ≤14, range 0-17) 
13.0 [10.0, 15.0] 60 (69.0) 11.0 [9.0, 13.0] 80 (92.0) <0.00011 
Domains within the CGA  
Activities of Daily Living 
(ADL; cut-off ≤5, range 0-6) 
6.0 [5.5, 6.0] 12 (13.8) 6.0 [5.5, 6.0] 16 (18.4) 0.0771 
Instrumental Activities of Daily 
Living (IADL; cut-off ≤7, range 0-
8) 
7.0 [6.0, 8.0] 44 (50.6) 6.0 [4.0, 8.0] 61 (70.1) <0.00011 
Mini Nutritional Assessment 
(MNA; cut-off ≤23.5, range 0-30) 
23.5 [21.0, 27.0]  44 (50.6) 21.0 [18.0, 23.5] 66 (75.9) <0.00011 
Mini Mental State Examination 
(MMSE; cut-off <24, range 0-30) 
26.0 [24.8, 28.0] 15 (17.4) 27.0 [25.0, 29.0] 15 (17.4) 0.0031 
Geriatric Depression Scale  
(GDS; cut-off ≥6, range 0-15) 
2.0 [1.0, 4.0] 15 (17.2) 3.0 [1.0, 6.0] 25 (28.7) 0.0011 
Tinetti balance and gait 
(Tinetti; cut-off ≤24, range 0-28) 
26.0 [25.0, 27.0] 24 (27.9) 26.0 [24.0, 27.0] 30 (34.5) 0.1591 
Cumulative Illness Rating Scale 
for Geriatrics (CIRS-G)* 
 65 (74.7)  68 (78.2) 0.2502 
Comprehensive Geriatric 
Assessment (CGA)* 
 62 (71.3)  73 (83.9) 0.0072 
a Only patients assessed at both dates were included in the statistical analysis; 1Wilcoxon signed rank test (comparison of numerical scores); 
2Mc Nemar’s Exact test (comparison of proportions); Q1: 25% percentile, Q3: 75% percentile; *proportions, no numerical score 
 
